Cargando…

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study

IMPORTANCE: The combination of prostate-specific antigen (PSA) testing with magnetic resonance imaging (MRI) for prostate cancer detection has rarely been evaluated in a screening context. The STHLM3-MRI screening-by-invitation study (NCT03377881) has reported the benefits of using MRI with subseque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Shuang, Discacciati, Andrea, Eklund, Martin, Heintz, Emelie, Östensson, Ellinor, Elfström, K. Miriam, Clements, Mark S., Nordström, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650623/ https://www.ncbi.nlm.nih.gov/pubmed/36355382 http://dx.doi.org/10.1001/jamaoncol.2022.5252

Ejemplares similares

The economic burden of prostate cancer – a Swedish prevalence-based register study
por: Hao, Shuang, et al.
Publicado: (2020)

STHLM3-MRI study: Role of magnetic resonance imaging-targeted biopsy in prostate cancer screening
por: Gaur, Abhay S.
Publicado: (2022)

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
por: Nordström, Tobias, et al.
Publicado: (2019)

The cost-effectiveness of prostate cancer screening using the Stockholm3 test
por: Karlsson, Andreas A., et al.
Publicado: (2021)

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)
por: Olsson, Henrik, et al.
Publicado: (2020)

The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial Effects
por: Koitsalu, Marie, et al.
Publicado: (2021)

Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years
por: Östensson, Ellinor, et al.
Publicado: (2015)

Correction: Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years
por: Östensson, Ellinor, et al.
Publicado: (2015)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
por: Yun, Hyunkyung, et al.
Publicado: (2023)

The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study
por: Palsdottir, Thorgerdur, et al.
Publicado: (2019)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland
por: Ginindza, Themba G., et al.
Publicado: (2017)

Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite
por: Silfverschiöld, Maria, et al.
Publicado: (2019)

The economic burden of low back pain in KwaZulu-Natal, South Africa: A prevalence-based cost-of-illness analysis from the healthcare provider’s perspective
por: Kahere, Morris, et al.
Publicado: (2022)

Mapping evidence on the distribution of the costs associated with cancer of prostate, cervix, and female breast in the sub-Saharan Africa: protocol for a scoping review
por: Ngcamphalala, Cebisile, et al.
Publicado: (2021)

Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study
por: Aarnio, Riina, et al.
Publicado: (2020)

Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?
por: Andersson, Sonia, et al.
Publicado: (2018)

Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education
por: Andersson, Sonia, et al.
Publicado: (2019)

Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
por: Callender, Thomas, et al.
Publicado: (2021)

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
por: Nordström, Tobias, et al.
Publicado: (2017)

Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study
por: Boesen, Lars, et al.
Publicado: (2018)

Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study
por: Palsdottir, Thorgerdur, et al.
Publicado: (2019)

Self-sampling for high-risk human papillomavirus as a follow-up alternative after treatment of high-grade cervical intraepithelial neoplasia
por: Östensson, Ellinor, et al.
Publicado: (2021)

Cost-Effectiveness of Liquid Biopsy for Colorectal Cancer Screening in Patients Who Are Unscreened
por: Aziz, Zainab, et al.
Publicado: (2023)

Perceived cervical cancer risk among women treated for high-grade cervical intraepithelial neoplasia: The importance of specific knowledge
por: Andersson, Sonia, et al.
Publicado: (2017)

Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis
por: Elwenspoek, Martha M. C., et al.
Publicado: (2019)

Magnetic Resonance Imaging–Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer
por: Jayadevan, Rajiv, et al.
Publicado: (2019)

Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination
por: Östensson, Ellinor, et al.
Publicado: (2015)

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging
por: Robinson, David, et al.
Publicado: (2023)

Age, margin status, high-risk human papillomavirus and cytology independently predict recurrent high-grade cervical intraepithelial neoplasia up to 6 years after treatment
por: Andersson, Sonia, et al.
Publicado: (2021)

The economic burden of cervical cancer in Eswatini: Societal perspective
por: Ngcamphalala, Cebisile, et al.
Publicado: (2021)

The economic burden of prostate cancer in Eswatini
por: Ngcamphalala, Cebisile, et al.
Publicado: (2022)

Cost-effectiveness of Screening for Atrial Fibrillation Using Wearable Devices
por: Chen, Wanyi, et al.
Publicado: (2022)

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy
por: Ström, Peter, et al.
Publicado: (2020)

The Prognostic Role of LRIG Proteins in Endometrial Cancer
por: Razumova, Zoia, et al.
Publicado: (2021)

Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension
por: Liao, Chia-Te, et al.
Publicado: (2023)

Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling
por: Lei, Jiayao, et al.
Publicado: (2022)

Association Between Risk of COVID-19 Infection in Nonimmune Individuals and COVID-19 Immunity in Their Family Members
por: Nordström, Peter, et al.
Publicado: (2021)

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cvoh1srmjlnhrbk9ggkheev49u